Clinical Trial Update: Neuroprotective Role of Erythropoietin in Perinatal Asphyxia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trials evaluating the neuroprotective effect of erythropoietin in perinatal asphyxia have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perinatal Asphyxia

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Sheri Kashmir Institute of Medical Sciences | Conditions: Perinatal Asphyxia | Phase 2, Phase 3 | Status: COMPLETED